Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues
Autor(a) principal: | |
---|---|
Data de Publicação: | 2014 |
Outros Autores: | , , , , , |
Tipo de documento: | Artigo |
Idioma: | por eng |
Título da fonte: | Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
Texto Completo: | https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185 |
Resumo: | Introduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal. |
id |
RCAP_b8d7f8f1800313bfa191c90e1cf010f6 |
---|---|
oai_identifier_str |
oai:ojs.www.actamedicaportuguesa.com:article/5185 |
network_acronym_str |
RCAP |
network_name_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository_id_str |
7160 |
spelling |
Long-Term Home Oxygen Therapy in Children: Evidences and Open IssuesOxigenoterapia Domiciliária de Longa Duração na Criança: Evidências e Questões em AbertoIntroduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal.Introdução: Oxigenoterapia domiciliária de longa duração está indicada em doentes com hipoxémia crónica. Pretendemos descrever a população em programa de oxigenoterapia domiciliária de longa duração acompanhada numa Unidade de Pneumologia Pediátrica de Hospital Terciário entre 2003-2012 e comparar com revisão de 1991-2000; verificar conformidade com orientações nacionais e internacionais, refletindo sobre necessidade de orientações nacionais especificamente pediátricas, inexistentes em Portugal.Material e Métodos: Estudo retrospetivo, descritivo e comparativo por consulta de processo clínico. Pesquisa de orientações sobre oxigenoterapia em idade pediátrica.Resultados: Incluímos 86 doentes (59,3% rapazes). A idade mediana de início da oxigenoterapia foi 0,0 (0,0-216,0) meses e a duração mediana de 15,0 (3,0-223,0) meses. O diagnóstico mais frequente foi displasia broncopulmonar (53,5%), seguindo-se bronquiolite obliterante (14,0%), doença neurológica (10,5%), fibrose quística (8,1%), síndromes polimalformativas (5,8%), doença de células falciformes (3,5%), outras doenças pulmonares neonatais (2,3%) e doenças pulmonares intersticiais (2,3%). Mantêm acompanhamento 53 (61,6%) doentes, 38 mantendo oxigenoterapia; 12 (13,9%) faleceram. O tempo mediano de seguimento foi 39,5 (1,0-246,0) meses, mínimo nas outras doenças pulmonares neonatais e máximo na fibrose quística. Comparativamente ao estudo anterior revela aumento relativo dos lactentes com bronquiolite obliterante e displasia broncopulmonar, aumento da duração nestes últimos e inclusãode doentes neurológicos e hematológicos.Discussão: A prescrição de oxigenoterapia domiciliária de longa duração em pediatria ocorre sobretudo em doenças específicas dos lactentes e idade pré-escolar. Doentes neurológicos e hematológicos são novos grupos de prescrição, à semelhança da literatura internacional.Conclusão: O conhecimento da realidade nacional e orientações pediátricas são relevantes para organização de cuidados eprescrição racional.Palavras-chave: Criança; Cuidados de Longa Duração;Insuficiência Respiratória; Oxigenoterapia.Ordem dos Médicos2014-12-30info:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfapplication/pdfapplication/octet-streamhttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185oai:ojs.www.actamedicaportuguesa.com:article/5185Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 717-725Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 717-7251646-07580870-399Xreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAPporenghttps://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4145https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4247https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/7313Oliveira, LiaCoelho, JoanaFerreira, RosárioNunes, TeresaSaianda, AnaPereira, LuisaBandeira, Teresainfo:eu-repo/semantics/openAccess2022-12-20T11:04:14Zoai:ojs.www.actamedicaportuguesa.com:article/5185Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T16:19:02.618473Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse |
dc.title.none.fl_str_mv |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues Oxigenoterapia Domiciliária de Longa Duração na Criança: Evidências e Questões em Aberto |
title |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
spellingShingle |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues Oliveira, Lia |
title_short |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
title_full |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
title_fullStr |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
title_full_unstemmed |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
title_sort |
Long-Term Home Oxygen Therapy in Children: Evidences and Open Issues |
author |
Oliveira, Lia |
author_facet |
Oliveira, Lia Coelho, Joana Ferreira, Rosário Nunes, Teresa Saianda, Ana Pereira, Luisa Bandeira, Teresa |
author_role |
author |
author2 |
Coelho, Joana Ferreira, Rosário Nunes, Teresa Saianda, Ana Pereira, Luisa Bandeira, Teresa |
author2_role |
author author author author author author |
dc.contributor.author.fl_str_mv |
Oliveira, Lia Coelho, Joana Ferreira, Rosário Nunes, Teresa Saianda, Ana Pereira, Luisa Bandeira, Teresa |
description |
Introduction: Long-term home oxygen therapy is indicated for patients with chronic hypoxemia. We intend to describe pediatric population on long-term home oxygen therapy followed-up at Pediatric Respiratory Unit of a tertiary care hospital between 2003-2012 and to compare with previous 1991-2000 review; to verify conformity with international and national recommendations and need for specific pediatric national guidelines, non-existent in Portugal.Material and Methods: Retrospective, descriptive and comparative study based on clinical files review. Review the guidelines for oxygen therapy in pediatric population.Results: We studied 86 patients (59.3% males). The median age at the beginning of oxygen therapy was 0.0 (0.0-216.0) months, with a median duration of 15.0 (3.0-223.0) months. The most frequent diagnosis was bronchopulmonary dysplasia (53.5%), followed by bronchiolitis obliterans (14.0%), neurologic disorders (10.5%), cystic fibrosis (8.1%), miscellaneous syndromes (5.8%), sickle-cell disease (3.5%), other neonatal lung diseases (2.3%) and interstitial lung diseases (2.3%). Are maintained on follow-up 53 (61.6%) patients, 38 on oxygen therapy; 12 (13.9%) died. The median time of follow-up was 39.5 (1.0-246.0) months, minim on other neonatal lung diseases and maximum on cystic fibrosis. Comparing with previous review, this shows a relative increase in bronchiolitis obliterans and bronchopulmonary dysplasia patients, with increased duration in the latter, and inclusion of neurologic and hematologic patients.Discussion: Prescription of long-term oxygen therapy in pediatric age mainly occurs in specific diseases of infants and pre-school aged. Neurologic and hematologic patients represent new indications, similarly to international publications.Conclusion: The knowledge of national reality and pediatric orientations are needed for care plans and rational prescription.Keywords: Child; Long-Term Care; Respiratory Insufficiency; Oxygen Inhalation Therapy; Portugal. |
publishDate |
2014 |
dc.date.none.fl_str_mv |
2014-12-30 |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185 oai:ojs.www.actamedicaportuguesa.com:article/5185 |
url |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185 |
identifier_str_mv |
oai:ojs.www.actamedicaportuguesa.com:article/5185 |
dc.language.iso.fl_str_mv |
por eng |
language |
por eng |
dc.relation.none.fl_str_mv |
https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4145 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/4247 https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/5185/7313 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf application/pdf application/octet-stream |
dc.publisher.none.fl_str_mv |
Ordem dos Médicos |
publisher.none.fl_str_mv |
Ordem dos Médicos |
dc.source.none.fl_str_mv |
Acta Médica Portuguesa; Vol. 27 No. 6 (2014): November-December; 717-725 Acta Médica Portuguesa; Vol. 27 N.º 6 (2014): Novembro-Dezembro; 717-725 1646-0758 0870-399X reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação instacron:RCAAP |
instname_str |
Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
instacron_str |
RCAAP |
institution |
RCAAP |
reponame_str |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
collection |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) |
repository.name.fl_str_mv |
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação |
repository.mail.fl_str_mv |
|
_version_ |
1799130641469538304 |